Title | Type | SJR | H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | %Female (2015) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
71 | European Heart Journal - Cardiovascular Pharmacotherapy | journal | 40 | 49 | 0 | 1388 | 0 | 0 | 0.00 | 28.33 | 20.16 | ||
70 | HIV Clinical Trials | journal | 1.027 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
69 | Journal of Pharmaceutical Health Care and Sciences | journal | 10 | 29 | 0 | 636 | 0 | 0 | 0.00 | 21.93 | 27.50 | ||
68 | Klinik Psikofarmakoloji Bulteni | journal | 0.178 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
67 | npj Breast Cancer | journal | 46 | 14 | 0 | 400 | 0 | 0 | 0.00 | 28.57 | 47.62 | ||
66 | Journal of Prescribing Practice | journal | 2 | 7 | 1 | 179 | 0 | 1 | 0.00 | 25.57 | 100.00 | ||
65 | Prescriber | journal | 0.123 Q4 | 4 | 7 | 1 | 107 | 0 | 1 | 0.00 | 15.29 | 28.57 | |
64 | MeReC Bulletin | journal | 0.123 Q4 | 7 | 0 | 5 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
63 | Molecular Therapy - Oncolytics | journal | 0.272 Q3 | 42 | 22 | 6 | 1480 | 4 | 5 | 0.67 | 67.27 | 34.53 | |
62 | Therapeutic Advances in Vaccines | journal | 1.335 Q1 | 5 | 0 | 6 | 0 | 36 | 6 | 6.00 | 0.00 | 0.00 | |
61 | BMC Pharmacology | journal | 0.805 Q2 | 48 | 0 | 8 | 0 | 32 | 8 | 0.00 | 0.00 | 0.00 | |
60 | BMC Clinical Pharmacology | journal | 0.557 Q2 | 43 | 0 | 14 | 0 | 44 | 14 | 0.00 | 0.00 | 0.00 | |
59 | PharmacoEconomics - Italian Research Articles | journal | 0.101 Q4 | 9 | 3 | 33 | 39 | 0 | 26 | 0.00 | 13.00 | 66.67 | |
58 | Pharmaceutical Medicine | journal | 0.252 Q3 | 25 | 24 | 63 | 793 | 41 | 52 | 0.49 | 33.04 | 35.71 | |
57 | Therapeutic Advances in Drug Safety | journal | 1.451 Q1 | 46 | 23 | 68 | 866 | 288 | 62 | 4.59 | 37.65 | 47.14 | |
56 | Therapeutic Advances in Cardiovascular Disease | journal | 0.595 Q2 | 41 | 47 | 74 | 1691 | 124 | 62 | 1.61 | 35.98 | 27.27 | |
55 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 17 | 82 | 903 | 222 | 80 | 2.17 | 53.12 | 35.21 | ||
54 | Therapeutic Advances in Respiratory Disease | journal | 0.763 Q2 | 50 | 32 | 85 | 1302 | 225 | 75 | 2.44 | 40.69 | 30.85 | |
53 | HIV Research and Clinical Practice | journal | 54 | 28 | 100 | 890 | 211 | 97 | 2.05 | 31.79 | 42.20 | ||
52 | Antimicrobial Resistance and Infection Control | journal | 1.093 Q1 | 66 | 56 | 101 | 1772 | 295 | 89 | 2.92 | 31.64 | 45.95 | |
51 | AIDS Research and Therapy | journal | 0.851 Q2 | 49 | 44 | 109 | 1512 | 210 | 108 | 1.76 | 34.36 | 39.76 | |
50 | Expert Opinion on Emerging Drugs | journal | 1.051 Q2 | 54 | 50 | 125 | 4861 | 374 | 122 | 2.58 | 97.22 | 36.77 | |
49 | American Journal of Cardiovascular Drugs | journal | 0.920 Q2 | 60 | 44 | 128 | 2273 | 322 | 121 | 2.49 | 51.66 | 21.43 | |
48 | Paediatric Drugs | journal | 0.855 Q2 | 70 | 50 | 142 | 3028 | 340 | 136 | 2.56 | 60.56 | 56.74 | |
47 | BioDrugs | journal | 0.894 Q2 | 79 | 35 | 146 | 2111 | 483 | 141 | 3.39 | 60.31 | 42.31 | |
46 | Biopharmaceutics and Drug Disposition | journal | 0.733 Q2 | 65 | 52 | 149 | 1987 | 408 | 144 | 2.66 | 38.21 | 28.36 | |
45 | Clinical Pharmacist | journal | 0.111 Q4 | 11 | 69 | 153 | 568 | 4 | 99 | 0.01 | 8.23 | 54.90 | |
44 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | 35.20 | |
43 | Pharmaceutical Statistics | journal | 1.180 Q1 | 46 | 57 | 160 | 1388 | 177 | 149 | 1.20 | 24.35 | 32.10 | |
42 | Psychiatry and Clinical Psychopharmacology | journal | 24 | 65 | 167 | 2023 | 64 | 145 | 0.35 | 31.12 | 38.26 | ||
41 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.110 Q1 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | 30.39 | |
40 | European Journal of Contraception and Reproductive Health Care | journal | 0.653 Q2 | 53 | 52 | 179 | 1449 | 232 | 169 | 1.30 | 27.87 | 64.76 | |
39 | Cardiovascular Therapeutics | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | 29.02 | |
38 | Journal of Chemotherapy | journal | 0.512 Q2 | 56 | 70 | 195 | 1923 | 277 | 175 | 1.28 | 27.47 | 42.62 | |
37 | Drugs and Therapy Perspectives | journal | 0.112 Q4 | 13 | 72 | 216 | 1854 | 12 | 216 | 0.06 | 25.75 | 55.77 | |
36 | Clinical Pharmacokinetics | journal | 1.664 Q1 | 184 | 108 | 217 | 5585 | 1271 | 210 | 5.60 | 51.71 | 35.35 | |
35 | Journal of Oncology Pharmacy Practice | journal | 0.424 Q3 | 44 | 50 | 227 | 1205 | 260 | 214 | 1.01 | 24.10 | 46.41 | |
34 | Clinical Practice | journal | 0.133 Q4 | 10 | 5 | 230 | 87 | 60 | 193 | 0.27 | 17.40 | 54.55 | |
33 | Expert Opinion on Orphan Drugs | journal | 0.213 Q3 | 27 | 124 | 230 | 10230 | 120 | 227 | 0.52 | 82.50 | 43.06 | |
32 | Fundamental and Clinical Pharmacology | journal | 0.637 Q2 | 85 | 64 | 232 | 2798 | 485 | 232 | 2.39 | 43.72 | 48.31 | |
31 | Human Psychopharmacology | journal | 0.974 Q2 | 86 | 52 | 232 | 2845 | 657 | 227 | 3.03 | 54.71 | 42.80 | |
30 | Expert Review of Clinical Pharmacology | journal | 0.817 Q2 | 60 | 58 | 249 | 4113 | 574 | 215 | 2.41 | 70.91 | 34.68 | |
29 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.818 Q2 | 61 | 103 | 253 | 4429 | 519 | 243 | 1.81 | 43.00 | 41.37 | |
28 | CNS Drugs | journal | 1.767 Q1 | 129 | 77 | 270 | 6587 | 1463 | 254 | 5.60 | 85.55 | 44.82 | |
27 | Drugs and Aging | journal | 1.389 Q1 | 109 | 98 | 280 | 6080 | 1032 | 265 | 3.45 | 62.04 | 46.03 | |
26 | HIV Medicine | journal | 1.967 Q1 | 86 | 99 | 287 | 3211 | 989 | 264 | 3.14 | 32.43 | 43.36 | |
25 | Journal of Biomedical Science | journal | 1.316 Q1 | 110 | 100 | 300 | 5106 | 1068 | 300 | 3.36 | 51.06 | 41.41 | |
24 | Drug Safety | journal | 1.365 Q1 | 140 | 104 | 320 | 5108 | 1101 | 281 | 3.60 | 49.12 | 46.24 | |
23 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.708 Q2 | 81 | 124 | 339 | 3722 | 717 | 334 | 2.22 | 30.02 | 45.07 | |
22 | Expert Opinion on Drug Safety | journal | 1.058 Q1 | 90 | 164 | 341 | 12223 | 1142 | 332 | 3.37 | 74.53 | 37.57 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®